Antioxidant Supplements During Cancer Treatment

Antioxidant supplements are widely marketed as protective, but during cancer treatment the picture is more complicated. Current evidence raises real concerns about taking them alongside chemotherapy or radiation, and oncologists generally advise caution until more research is available.

What Antioxidants Do in the Body

Antioxidants are compounds that help regulate oxidative stress pathways that can otherwise damage cells. They neutralize reactive oxygen species (free radicals) generated during normal cell activity and support the body's preventive and repair mechanisms against oxidative cell damage. According to the NIH Office of Dietary Supplements (ODS), this physiological role is supported by strong evidence.

Two well-studied antioxidant nutrients are vitamin C and vitamin E.

• Vitamin C acts as an important physiological antioxidant that limits damage from free radicals and helps regenerate other antioxidants, including vitamin E. It is also required for the biosynthesis of collagen, L-carnitine, and certain neurotransmitters. The ODS notes these roles are supported by strong evidence.
• Vitamin E is a fat-soluble antioxidant that stops the production of reactive oxygen species formed when fat undergoes oxidation, protecting cells from free-radical damage. It also contributes to normal immune function. The ODS rates this evidence as strong.

These statements have not been evaluated by the FDA, and supplements are not intended to diagnose, treat, cure, or prevent any disease.

The Core Concern During Cancer Treatment

Many chemotherapy drugs and radiation therapy work precisely by generating reactive oxygen species that damage and kill cancer cells. Antioxidants, by design, neutralize those same reactive oxygen species. This creates a direct theoretical conflict: antioxidant supplements taken during treatment may reduce the effectiveness of treatments that work by generating reactive oxygen species.

This concern is not purely theoretical. A 2019 and 2020 study found that antioxidant supplements, including vitamins A, C, and E, carotenoids, and coenzyme Q10, taken during chemotherapy were linked with higher risks of breast cancer recurrence and death. The ODS cites this finding as a reason for caution.

The ODS also notes that oncologists generally advise against antioxidant supplements during cancer treatment because they might reduce effectiveness by protecting cancer cells from oxidative damage, though evidence is mixed and further research is needed.

What the Evidence Does and Does Not Show

It is important to be clear about what research has and has not established. Grading evidence honestly, as the NIH does, means acknowledging gaps.

• Antioxidant supplements prevent cancer: Insufficient evidence. The NIH ODS and NCCIH both rate this claim as unsupported by current research.
• Antioxidant supplements prevent cardiovascular disease: Insufficient evidence.
• Vitamin C supplements reduce cancer risk: Insufficient evidence, per the ODS.
• Vitamin E supplements prevent cancer: Insufficient evidence, per the ODS.
• AREDS and AREDS2 formula (antioxidants plus zinc) for existing intermediate or advanced age-related macular degeneration: Moderate evidence that this specific formula can slow progression to advanced disease in people who already have the condition. This is a narrow, condition-specific finding and does not generalize to cancer treatment.

Safety and Upper Limits

Antioxidant supplements are not automatically safe. The ODS has established Tolerable Upper Intake Levels (ULs) for several antioxidant nutrients.

• Vitamin C: The adult UL is 2,000 mg per day, based on the risk of gastrointestinal effects such as diarrhea and cramps at higher intakes. The adult reference intake is 90 mg per day for men and 75 mg per day for women aged 19 and older. The ODS notes the UL does not apply to people receiving vitamin C for medical treatment, who should be under a physician's care.
• Vitamin E: The adult UL is 1,000 mg per day for supplemental alpha-tocopherol (equivalent to 1,500 IU per day of the natural form or 1,100 IU per day of the synthetic form). This limit is based on the risk of hemorrhage. The adult reference intake is 15 mg per day.
• Beta-carotene: No adult UL has been formally established, but the US Preventive Services Task Force recommends against using beta-carotene supplements, particularly because high doses raise lung cancer and cardiovascular death risk, especially in people who smoke or have been exposed to asbestos.

Drug Interactions to Know About

Antioxidant supplements can interact with medications in ways that matter especially during cancer treatment. Always consult your oncologist or pharmacist before combining any supplement with prescription medicines.

• Chemotherapy and radiation therapy: It is uncertain whether high-dose vitamin C and other antioxidants protect tumor cells, protect normal tissue, or alter treatment effectiveness. People undergoing chemotherapy or radiation should consult their oncologist before taking vitamin C or other antioxidant supplements, especially in high doses.
• Anticoagulant and antiplatelet medications (such as warfarin): Vitamin E can inhibit platelet aggregation and antagonize vitamin K-dependent clotting factors. Large doses can increase bleeding risk, especially with low vitamin K intake. The ODS notes the threshold for a clinically significant effect is unknown but probably exceeds 400 IU per day.
• Statin and niacin therapy: A combination of vitamin E, vitamin C, selenium, and beta-carotene reduced the cholesterol-lowering effect of a niacin plus statin regimen in one study. Vitamin C alone, combined with other antioxidants, may also reduce the HDL-raising benefit of niacin plus simvastatin. Clinicians should monitor lipid levels in people taking both statins and antioxidant supplements.

Practical Takeaways

The physiology of antioxidants is well understood and their roles in normal cell function are supported by strong evidence. However, that same mechanism creates a plausible risk during cancer treatment, and at least one observational study has linked antioxidant supplement use during chemotherapy with worse outcomes.

No adult target intake has been established for antioxidants as a general category, and no universal upper limit applies across all antioxidant compounds. Individual nutrients like vitamin C and vitamin E do have established reference values and upper limits from the NIH ODS, but personal dosing decisions should be made with a clinician or pharmacist, not based on population reference values alone.

If you are currently in cancer treatment or planning to start, speak with your oncologist before taking any antioxidant supplement, including products labeled as natural or food-based. The evidence does not support self-supplementing with antioxidants during chemotherapy or radiation therapy without medical supervision.